Current medical therapy of inflammatory bowel disease

doi:10.3748/wjg.v6.i4.483

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 4

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1943)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

174

HTML

1435

Figures (1-2)

218

Tables (1-1)

116

Sum=1943

Aug 15, 2000 (publication date) through May 15, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Aug 15, 2000; 6(4): 483-489
Published online Aug 15, 2000. doi: 10.3748/wjg.v6.i4.483

Current medical therapy of inflammatory bowel disease

Kiron M. Das, Sherif A. Farag

Kiron M. Das, Sherif A. Farag, Department of Medicine, Division of Gastroenterology and Hepatology, and Crohn’s and Colitis Center of New Jersey, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, NJ 08903, USA

Author contributions: All authors contributed equally to the work.

Correspondence to: Kiron M.Das, M.D.,Ph.D. Chief, Div. of Gastroenterology & Hepatology, UMDNJ-Robert Wood Johnson Medical School, 1 Robert Wood Johnson Place, New Brunswick, NJ 0 8903, USA

Telephone: +1-732-2357784 Fax: +1-732-2357792

Received: June 9, 2000
Revised: June 12, 2000
Accepted: June 15, 2000
Published online: August 15, 2000

Abstract

Keywords: ulcerative colitis, Crohn’s disease, therapy, sulfasalazine, 5-aminosalicylic acid, glucocorticoids, immunosuppresive agents, immunomodulatory agents, antibi otics, nutrition